The ‘death rays’ that never were (Page)
https://www.swisstph.ch/fr/impact-stories/the-death-rays-that-never-were
research on the topic”, says Röösli. Many of them can be found among the signatories listed on the website 5G Appeal, for example. “If you regard anyone with a doctorate as a researcher, then there are indeed [...] topic”, he says. But it does make him nervous “when people talk utter nonsense – such as how Covid and 5G are supposedly connected. That’s when I feel responsible to set things straight”. However, for several
Digital System for a Better Health Care Management of Refugees (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/digital-system-for-a-better-health-care-management-of-refugees
covering for the time being the integrated management of childhood illnesses of children aged 2 months to 5 years. More than 12’800 consultations were made using the CDSS. The CDSS covering the management of [...] covering for the time being the integrated management of childhood illnesses of children aged 2 months to 5 years. More than 12’800 consultations were made using the CDSS. The CDSS covering the management of
“It is a privilege to be able to bring science to the bedside” (Page)
https://www.swisstph.ch/fr/impact-stories/it-is-a-privilege-to-be-able-to-bring-science-to-the-bedside
that we can now test the candidate in a broader population of people affected with malaria who weigh 5kg or more. The KALUMA trial is being conducted by Novartis in 14 countries across sub-Saharan Africa [...] partnered with Novartis to test a new formulation of Coartem for neonates and infants weighing less than 5 kg (following positive CALINA study results, the data have been submitted for regulatory review). It
Open House 2023: Venez visiter le nouveau Swiss TPH (Page)
https://www.swisstph.ch/fr/about/events/open-house-2023
nos scientifiques et experts. Toutes les conférences ont lieu dans les salles de séminaire 1, 4 et 5. Circuits de visite : Il y a un circuit de visite des laboratoires au 2ème étage et un circuit de visite
Integrating population and functional genomics with molecular epidemiology to explore the interaction between host and pathogen diversity in human... (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/integrating-population-and-functional-genomics-with-molecular-epidemiology-to-explore-the-interaction-between-host-and-pathogen-diversity-in-human-tuberculosis
Tuberculosis (TB) remains a global public health emergency with 1.5 million people dying from the disease every year. TB is caused by a group of closely related bacteria known as the Mycobacterium tuberculosis
Allg. Übersichtsberichte (Page)
https://www.swisstph.ch/fr/projects/ludok/aktuelle-berichte/allg-uebersichtsberichte
quelles sont les conséquences sanitaires de la pollution et quel est le niveau de conformité. En plus des 5 polluants classiques, le rapport considère également les PUNR, la suie, et d'autres polluants réglementés
Tuberculosis Research Against "Super Resistant Bacteria" (Page)
https://www.swisstph.ch/fr/news/20170905-tuberculosis-research
research to health systems. About Tuberculosis According to the World Health Organization, TB claims 5 000 lives each day. An estimated 480 000 people developed multidrug-resistant TB in the world in 2015
Noise (Page)
https://www.swisstph.ch/fr/topics/environment-and-health/noise
noise exposure. In addition, it is estimated that transportation noise causes 22,500 hospital days and 5'500 years of life lost each year. Read the publication Further Projects All Projects SiRENE - SiRENE
Accelerating the Fight against Malaria - World Malaria Day 2024 (Page)
https://www.swisstph.ch/fr/news/accelerating-the-fight-against-malaria-world-malaria-day-2024
been stalling. In 2022, over 600,000 people died from malaria, primarily children under the age of 5 in sub-Saharan Africa. People living in the most vulnerable circumstances – including young children
Technical Support and Capacity Building (Page)
https://www.swisstph.ch/fr/topics/malaria/technical-support-and-capacity-building
48% decline in all-cause mortality in children under the age of five between 2000 and 2010. The Phase 5 of NETCELL will tackle an enlarged scope of support, while at the same time deepen its structural impact